- Senate passes Drug Quality and Security Act
- ROUNDTABLE: Pharmacy’s future in sync with technology
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- Mylan launches generic drug for kidney transplant patients
- Roxane Labs' generic prostate drug gets tentative approval from FDA
PITTSBURGH — The Food and Drug Administration has approved a generic drug for hypertension made by Mylan.
Mylan announced Friday the approval of nifedipine extended-release tablets in the 30-mg, 60-mg and 90-mg strengths. The drug is a generic version of Bayer’s Adalat CC.
Nifedipine tablets had sales of around $82 million during the 12-month period ended in June, according to IMS Health.